In this context, overexpression of the oncogenic lncRNA MALAT1 in non-small cell lung cancer (NSCLC) tissue is related to reduced overall survival and could be a potential prognostic biomarker and therapeutic target in early-stage lung cancer (LC) (Gutschner et al., 2013; Huang et al., 2017; Lu et al., 2018). This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.